ARTC · Insider Trading
Art Technology Acquisition Corp. Class A Ordinary Shares
Every open-market purchase and sale reported by ARTC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2014-03-12 | Barbara D Boyan | Director | MIXED | +13,200 | +$12 |
| 2014-02-28 | Richard W. Rew II | Senior VP & General Counsel | MIXED | +4,369 | −$26.96K |
| 2014-02-05 | Bruce Prothro | Chief Regulatory Officer & SVP | Sell | −3,474 | −$168.80K |
| 2014-01-10 | Barbara D Boyan | Director | MIXED | — | −$178.90K |
| 2014-01-10 | Bruce Prothro | Chief Regulatory Officer & SVP | MIXED | — | −$739.95K |
| 2014-01-10 | Jean Woloszko | Chief Tech Officer & SVP R&D | MIXED | −5,682 | −$878.23K |
| 2014-01-06 | Bruce Prothro | Chief Regulatory Officer & SVP | MIXED | +12,136 | +$385.69K |
| 2013-12-20 | Barbara D Boyan | Director | MIXED | — | −$128.90K |
| 2013-12-20 | Jean Woloszko | Chief Technology Officer & SVP | MIXED | −6,000 | −$316.61K |
| 2013-12-18 | James L Pacek | Sr VP,Global Markets & Sales | MIXED | +2,033 | +$64.22K |
| 2013-10-31 | Jean Woloszko | Chief Technology Officer & SVP | Sell | −1,342 | −$50.93K |
| 2013-10-08 | James L Pacek | Sr VP, Strategic Business Unit | Sell | −2,500 | −$86.20K |
| 2013-06-21 | Scott Schaffner | SVP & GM SPORTS MEDICINE | A | +7,545 | +$8 |
| 2013-06-21 | Richard W. Rew II | Senior VP & General Counsel | A | +5,081 | +$5 |
| 2013-06-21 | Bruce Prothro | Chief Regulatory Officer & SVP | MIXED | +2,061 | −$90.43K |
| 2013-06-21 | David Fitzgerald | Board of Directors | A | +34,955 | +$35 |
| 2013-06-21 | Jean Woloszko | Chief Technical Officer & SVP | A | +6,097 | +$6 |
| 2013-06-21 | James L Pacek | Sr VP, Strategic Business Unit | A | +5,081 | +$5 |
| 2013-06-21 | Todd Newton | SVP, CFO & COO | A | +9,426 | +$9 |
| 2013-05-29 | Tord Lendau | Director | MIXED | — | −$257.69K |
| 2013-05-29 | Peter Wilson | Director | MIXED | +5,000 | −$92.15K |
| 2013-05-24 | Gregory Belinfanti | Director | A | +3,300 deriv. | — |
| 2013-05-24 | Christian Ahrens | Director | A | +3,300 deriv. | — |
| 2013-05-24 | OEP AC Holdings, LLC | 10%+ Owner | A | +26,400 deriv. | — |
| 2013-05-23 | Tord Lendau | Director | A | +3,300 | +$3 |
| 2013-05-23 | Barbara D Boyan | Director | A | +3,300 | +$3 |
| 2013-05-23 | James Foster | Director | A | +3,300 | +$3 |
| 2013-05-23 | Peter Wilson | Director | A | +3,300 | +$3 |
| 2013-05-23 | Terrence E Geremski | Director | A | +3,300 | +$3 |
| 2013-01-09 | James G Foster | Director | Sell | −10,500 | −$367.99K |
| 2012-12-31 | James G Foster | Director | M | +30,000 | +$483.00K |
| 2012-11-15 | David Fitzgerald | Board of Directors | MIXED | +25,000 | −$118.95K |
| 2012-08-09 | James G Foster | Director | MIXED | +15,000 | −$355.85K |
| 2012-07-06 | Bruce Prothro | Chief Regulatory Officer & SVP | Sell | −2,167 | −$65.01K |
| 2012-05-30 | Terrence E Geremski | Director | A | +4,312 | +$4 |
| 2012-05-30 | Peter Wilson | Director | MIXED | +9,312 | −$67.15K |
| 2012-05-29 | Barbara D Boyan | Director | A | +4,312 | +$4 |
| 2012-05-29 | Christian Ahrens | Director | A | +4,312 deriv. | — |
| 2012-05-29 | James G Foster | Director | A | +4,312 | +$4 |
| 2012-05-29 | Gregory Belinfanti | Director | A | +4,312 deriv. | — |
| 2012-05-29 | Tord Lendau | Director | MIXED | +4,312 | −$192.30K |
| 2012-05-29 | One Equity Partners III, L.P. | 10%+ Owner | A | +34,496 deriv. | — |
| 2012-03-01 | James L Pacek | Sr VP, Strategic Business Unit | MIXED | +3,518 | −$36.45K |
| 2012-03-01 | Bruce Prothro | Chief Regulatory Officer & SVP | A | +4,715 | +$5 |
| 2012-03-01 | Richard W. Rew II | Senior VP & General Counsel | MIXED | +4,633 | −$2.15K |
| 2012-03-01 | Todd Newton | SVP, CFO & COO | MIXED | +13,457 | +$104.81K |
| 2012-03-01 | David Fitzgerald | Board of Directors | MIXED | +42,000 | +$130.75K |
| 2012-03-01 | Andrew Miclot | SVP & GM ENT Tech | MIXED | +13,812 | −$8.78K |
| 2012-03-01 | Jean Woloszko | CTO and SVP | A | +5,894 | +$154.66K |
| 2012-03-01 | Scott Schaffner | SVP & GM SPORTS MEDICINE | MIXED | +15,401 | −$33.34K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ARTC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.